Advisory Services Network’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Advisory Services Network’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-76	Closed	-$7K	–	3712
2021 Q2	$7K	Buy	+76	New	+$6.17K	﹤0.01%	2983
2021 Q1	–	Sell	-48	Closed	-$4K	–	3392
2020 Q4	$4K	Hold	48	–	–	﹤0.01%	2840
2020 Q3	$3K	Buy	+48	New	+$3.15K	﹤0.01%	3054
2020 Q2	–	Sell	-48	Closed	-$2K	–	3190
2020 Q1	$2K	Buy	+48	New	+$2.19K	﹤0.01%	2831
2019 Q2	–	Sell	-200	Closed	-$10K	–	3011
2019 Q1	$10K	Buy	+200	New	+$8.64K	﹤0.01%	1872

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisory Services Network's BHVN Position: Q3 2021 in Review

Advisory Services Network sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2021, closing a stake of 76 shares — an estimated $7K sold.

Advisory Services Network first reported a position in BHVN in Q1 2019 and held it in 5 quarters. The position peaked at $10K in Q1 2019. 249 funds tracked by Wall St. Rank hold BHVN as of Q3 2021.

Advisory Services Network reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 76 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2021, an estimated $7K.
Advisory Services Network first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2019 and held it in 5 quarters.
Advisory Services Network's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10K in Q1 2019.
249 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.